Peking University First Hospital
Clinical trials sponsored by Peking University First Hospital, explained in plain language.
-
Scientists test 'Living Pharmacy' to free diabetics from insulin shots
Disease control Not yet recruitingThis study is testing whether insulin-producing cells grown from stem cells can help control diabetes. Researchers will infuse these lab-grown cells into 30 adults who have had diabetes for over 5 years and require insulin. The main goal is to see if the treatment is safe and if …
Phase: NA • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Apr 04, 2026 00:50 UTC
-
New combo therapy aims to stop aggressive bladder cancer from coming back
Disease control Not yet recruitingThis study is testing whether a targeted drug called disitamab vedotin, combined with radiation therapy, works better than standard chemotherapy to prevent cancer from returning after surgery for upper urinary tract cancer. The trial is for patients whose cancer tests positive fo…
Phase: PHASE2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Stool test could guide simpler stomach bug treatment
Disease control Not yet recruitingThis study is testing a simpler, two-drug treatment for a common stomach bacteria called H. pylori. It will involve about 70 adults who have not been treated before. Doctors will first use a stool test to check if the bacteria are likely to be resistant to the main antibiotic, an…
Phase: NA • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New drug combo aims to stop prostate Cancer's return
Disease control Not yet recruitingThis study is testing if adding a newer drug called darolutamide to standard hormone therapy (ADT) can better prevent prostate cancer from returning after surgery. It will involve about 40 men who had surgery for high-risk prostate cancer but did not have extensive lymph node rem…
Phase: PHASE2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Chasing the last cancer cell: can a transplant lock in remission for amyloidosis?
Disease control Not yet recruitingThis study aims to see if a stem cell transplant can help patients with AL amyloidosis who have responded well to initial drug therapy but still have tiny amounts of disease left. Researchers will first check 50 patients for this 'minimal residual disease' (MRD) after drug treatm…
Phase: NA • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
MRI scans could help men avoid unnecessary prostate biopsies
Diagnosis Not yet recruitingThis study is testing whether doctors can use repeated MRI scans to better decide when men with suspicious prostate findings actually need a biopsy. Researchers will follow 1,000 men to see if watching how MRI images change over time can safely reduce the number of unnecessary bi…
Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated Apr 03, 2026 14:42 UTC
-
New scan could pinpoint hidden cancer spots
Diagnosis Not yet recruitingThis study is testing a new type of PET/CT scan that targets a specific protein (BCMA) found on multiple myeloma cancer cells. It aims to see if this scan can more accurately find and measure cancer spots throughout the body compared to current methods. The study will involve 300…
Phase: PHASE2, PHASE3 • Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated Mar 18, 2026 14:41 UTC
-
Drug trial aims to stop painful urination crisis after prostate tests
Prevention Not yet recruitingThis study tests whether taking Tamsulosin (a common prostate medication) before and after a prostate biopsy can prevent painful urination problems. Researchers will compare 1,844 men who take the medication to those who don't to see if it reduces the risk of being unable to urin…
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Prevention
Last updated Mar 25, 2026 14:09 UTC
-
New drug combo tested to help patients bounce back faster from surgery
Symptom relief Not yet recruitingThis study aims to see if two common anesthesia drugs, dexmedetomidine and esketamine, can help people feel better after surgery. Researchers will test each drug alone and together in 316 adults having surgery under general anesthesia. The main goal is to see if these drugs impro…
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated Apr 04, 2026 00:50 UTC
-
New nasal spray aims to ease Kids' pain after common surgery
Symptom relief Not yet recruitingThis study is testing whether a combination nasal spray (dexmedetomidine-esketamine) given during surgery can better manage pain in children recovering from tonsil and adenoid removal. It will involve 160 children aged 3 to 7 years. The goal is to see if this approach reduces pai…
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated Apr 03, 2026 14:41 UTC
-
Can a new anesthesia mix stop Post-Surgery brain fog in seniors?
Symptom relief Not yet recruitingThis study aims to see if a specific way of giving anesthesia drugs can help protect older patients' memory and thinking skills after surgery. Researchers will compare two different levels of anesthesia depth, both delivered by a precise IV pump that mixes two key drugs in a fixe…
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated Mar 23, 2026 15:16 UTC
-
Massive study aims to solve blood clot mystery in liver disease
Knowledge-focused Not yet recruitingThis study aims to better understand a dangerous blood clot complication called portal vein thrombosis (PVT) in people with liver cirrhosis. It will follow about 2,500 patients over time to identify who is most at risk, measure how the clots affect health and survival, and compar…
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC